Feb 26, 2024 · Bosutinib is used in adults and children at least 1 year old to treat a type of blood cancer called Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in chronic phase. Bosutinib is also used to treat adults with Ph+ CML in accelerated or blast phase.

Bosutinib, sold under the brand name Bosulif, is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia. [2] Originally synthesized by Wyeth, it is being developed by Pfizer. [citation needed]

Apr 1, 2025 · Bosutinib is used to treat chronic phase (CP) Philadelphia chromosome-positive chronic myelogenous leukemia (Ph+ CML) in patients who are newly-diagnosed or who have taken other medicines that did not work well.

BOSULIF is part of a group of medicines called tyrosine kinase inhibitors (TKIs). TKIs can block BCR-ABL function, slowing the growth of leukemia cells. For some patients, this allows their white blood cells to return to normal levels. Not taking your …

Bosulif (bosutinib monohydrate) is used to treat cancer but is known as a targeted treatment because it inhibits specific kinases that promote the growth of chronic myeloid leukemia (CML).

Feb 28, 2025 · Bosulif (bosutinib) is commonly used to treat certain types of Philadelphia chromosome-positive (Ph+) chronic myeloid leukemia (CML), which is a form of blood cancer.

Bosutinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps stop the spread of cancer cells.

Bosutinib is approved to treat: Chronic myelogenous leukemia (CML) that is Philadelphia chromosome positive. It is used: In adults and children aged 1 year and older with chronic phase CML that is newly diagnosed or cannot be treated with or did not respond to other treatment.

Verify pregnancy status in females of reproductive potential prior to initiation. lefamulin will increase the level or effect of bosutinib by affecting hepatic/intestinal enzyme CYP3A4...

Bosutinib is a type of targeted cancer drug. It is also known as Bosulif. You pronounce bosutinib as boe-sue-ti-nib. It is a treatment for people with newly diagnosed chronic myeloid leukaemia (CML) that has an abnormal chromosome called the Philadelphia chromosome.